SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-22-006964
Filing Date
2022-11-01
Accepted
2022-11-01 16:15:52
Documents
64
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q apto20220930_10q.htm   iXBRL 10-Q 975859
2 EXHIBIT 31.1 ex_439394.htm EX-31.1 12339
3 EXHIBIT 31.2 ex_439395.htm EX-31.2 12311
4 EXHIBIT 32.1 ex_439396.htm EX-32.1 3393
5 EXHIBIT 32.2 ex_439397.htm EX-32.2 3411
11 logo.jpg GRAPHIC 5225
  Complete submission text file 0001171843-22-006964.txt   4646607

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA apto-20220930.xsd EX-101.SCH 45143
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apto-20220930_cal.xml EX-101.CAL 29137
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apto-20220930_def.xml EX-101.DEF 264133
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE apto-20220930_lab.xml EX-101.LAB 240782
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apto-20220930_pre.xml EX-101.PRE 290416
58 EXTRACTED XBRL INSTANCE DOCUMENT apto20220930_10q_htm.xml XML 789112
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32001 | Film No.: 221350427
SIC: 2836 Biological Products, (No Diagnostic Substances)